(Q55981839)
Statements
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial (English)
J Christopher Kingswood
Elżbieta Radzikowska
Bernard A Zonnenberg
Michael Frost
Matthias Sauter
Norio Nonomura
Susanne Brakemeier
Petrus J de Vries
Vicky H Whittemore
David Chen
Tarek Sahmoud
Gaurav Shah
Jeremie Lincy
David Lebwohl
1 March 2013